Delivery Order SPE2DB20D3103-SPE2DB22FM5C0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL. The $2,247.60 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., through the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive...
- This federal contract award, valued at $19,168.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The award was made as a firm-fixed-price delivery order contract, with a completion date of November 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $3,679.78, is for the delivery of Humulin R 500 Unit/mL KwikPen 3mL, a specialty medication used to manage diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,488.64 firm fixed price delivery order is for the supply of Humulin R 500 unit/mL Kwikpen 3mL medication. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. The company holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Humulin R 500 Unit/mL Kwikpen 3mL. The contract is a Delivery Order (DO) with a firm fixed price of $1,126.56 and a completion date of December 15, 2022. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $31,176.93, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML pharmaceutical products to the DLA. The contract has an ultimate completion date of September 19, 2023. This award is not associated with a specific set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., is a Delivery Order valued at $2,247.60 for the supply of Humulin R 500 Unit/mL Kwikpen 3mL medication. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of May 23, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $7,194.32 for the supply of Humulin R 500 unit/mL Kwikpen 3mL, a specialty pharmaceutical product. The award has an ultimate completion date of February 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award is for the delivery of Humulin R 500 Unit/mL KwikPen 3mL to the Defense Logistics Agency (DLA). The $4,042.34 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of Humulin R 500 unit/ml KwikPen 3ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,506.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with an ultimate completion date of February 8, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM5C0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humulin R 500 unit/mL KwikPen 3mL. The award, valued at $3,755.20, is a firm fixed-price delivery order with a completion date of February 2, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 2/1/22 |